[go: up one dir, main page]

MX2010004484A - Composicion para tratamiento de enfermedad de las articulaciones. - Google Patents

Composicion para tratamiento de enfermedad de las articulaciones.

Info

Publication number
MX2010004484A
MX2010004484A MX2010004484A MX2010004484A MX2010004484A MX 2010004484 A MX2010004484 A MX 2010004484A MX 2010004484 A MX2010004484 A MX 2010004484A MX 2010004484 A MX2010004484 A MX 2010004484A MX 2010004484 A MX2010004484 A MX 2010004484A
Authority
MX
Mexico
Prior art keywords
effect
preventing
cartilage
composition
joint disease
Prior art date
Application number
MX2010004484A
Other languages
English (en)
Inventor
Tatsuya Igarashi
Norimasa Iwasaki
Akio Minami
Yasuhiko Kasahara
Daisuke Kawamura
Nobuo Ohzawa
Mariko Imai
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2008/052999 external-priority patent/WO2008102855A1/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of MX2010004484A publication Critical patent/MX2010004484A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención provee una composición para tratar una enfermedad de las articulaciones que contiene como un ingrediente activo de la misma una sal de metal monovalente de ácido algínico para el cual se ha reducido el nivel de endotoxina del mismo hasta un grado que no induce sustancialmente inflamación o fiebre. Como resultado, es posible proveer una composición para tratar una enfermedad de las articulaciones que tiene los efectos de proteger el cartílago contra irritación mecánica, inhibir los cambios degenerativos en el cartílago causados por desgaste e inflamación, reparar los daños al cartílago, suprimir la inflamación y dolor del tejido de la articulación, inhibir la degeneración del tejido sinovial, e inhibir la destrucción osteocartilaginosa.
MX2010004484A 2007-10-24 2008-08-19 Composicion para tratamiento de enfermedad de las articulaciones. MX2010004484A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007277005 2007-10-24
PCT/JP2008/052999 WO2008102855A1 (ja) 2007-02-21 2008-02-21 軟骨疾患治療用組成物
PCT/JP2008/065065 WO2009054181A1 (ja) 2007-10-24 2008-08-19 関節疾患治療用組成物

Publications (1)

Publication Number Publication Date
MX2010004484A true MX2010004484A (es) 2010-07-06

Family

ID=40579288

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004484A MX2010004484A (es) 2007-10-24 2008-08-19 Composicion para tratamiento de enfermedad de las articulaciones.

Country Status (11)

Country Link
EP (1) EP2210621B1 (es)
JP (1) JP5491866B2 (es)
KR (1) KR101510494B1 (es)
CN (1) CN101835501B (es)
AU (1) AU2008315175B2 (es)
BR (1) BRPI0818719B1 (es)
CA (1) CA2703158C (es)
ES (1) ES2427730T3 (es)
MX (1) MX2010004484A (es)
NZ (1) NZ584869A (es)
WO (1) WO2009054181A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012085609A1 (en) * 2010-12-20 2012-06-28 Dept. Of Pathobiology Treatment of osteoarthritis by continuous intra-articular injection of alginate gel
US20140213524A1 (en) * 2011-08-23 2014-07-31 National University Corporation Hokkaido University Composition for regeneration of cartilage
WO2014084427A1 (ko) * 2012-11-30 2014-06-05 주식회사 이코바이오 알긴산을 포함하는 골관절염 예방 또는 치료용 조성물
KR102740598B1 (ko) * 2015-09-07 2024-12-09 모찌다 세이야쿠 가부시끼가이샤 알긴산 동결 건조 제제
EP3573633A1 (en) * 2017-01-26 2019-12-04 Aboca S.p.A. Societa' Agricola New compositions for the treatment of articular disorders
CN110520165A (zh) * 2017-03-02 2019-11-29 持田制药株式会社 纤维软骨组织损伤治疗用组合物
WO2018164128A1 (ja) * 2017-03-07 2018-09-13 持田製薬株式会社 アルギン酸液剤
WO2019182015A1 (ja) 2018-03-22 2019-09-26 持田製薬株式会社 非ステロイド性抗炎症性化合物結合アルギン酸誘導体
JPWO2022102093A1 (es) 2020-11-13 2022-05-19

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589591A (en) 1986-07-03 1996-12-31 Advanced Magnetics, Inc. Endotoxin-free polysaccharides
WO1993013136A1 (en) 1991-12-20 1993-07-08 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
JPH08269102A (ja) 1995-03-30 1996-10-15 Shiseido Co Ltd エンドトキシンフリーのβ１，３−グルカン及びその製造法並びに医療用ゲル素材
JPH09324001A (ja) 1996-04-02 1997-12-16 Kyowa Hakko Kogyo Co Ltd ヒアルロン酸ナトリウムの精製法
WO2000029449A1 (en) 1998-11-13 2000-05-25 Cp Kelco U.S. Inc. Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same
US7005274B1 (en) 1999-09-15 2006-02-28 Migenix Corp. Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
TW200307011A (en) * 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
JP2005036036A (ja) 2003-07-16 2005-02-10 Tanabe Seiyaku Co Ltd エンドトキシン除去方法
AU2005295927B2 (en) * 2004-10-12 2012-02-02 Fmc Biopolymer As Self-gelling alginate systems and uses thereof
JP5100980B2 (ja) * 2005-05-18 2012-12-19 株式会社クラレ 化学物質の精製方法
JP4986273B2 (ja) * 2005-09-15 2012-07-25 持田製薬株式会社 アルギン酸を含む創傷被覆材
WO2007083522A1 (ja) * 2006-01-18 2007-07-26 Next21 K. K. 医療用ゲル形成組成物，その組成物の投与デバイス及び薬剤放出制御担体
JP4838178B2 (ja) 2006-03-17 2011-12-14 京セラミタ株式会社 画像形成装置

Also Published As

Publication number Publication date
BRPI0818719A2 (pt) 2015-05-05
CN101835501B (zh) 2013-07-17
ES2427730T3 (es) 2013-10-31
EP2210621A1 (en) 2010-07-28
EP2210621B1 (en) 2013-07-24
NZ584869A (en) 2011-07-29
EP2210621A4 (en) 2010-11-17
KR20100088687A (ko) 2010-08-10
AU2008315175A1 (en) 2009-04-30
BRPI0818719B1 (pt) 2018-09-04
WO2009054181A1 (ja) 2009-04-30
JP5491866B2 (ja) 2014-05-14
CN101835501A (zh) 2010-09-15
KR101510494B1 (ko) 2015-04-08
CA2703158C (en) 2016-11-15
JPWO2009054181A1 (ja) 2011-03-03
AU2008315175B2 (en) 2013-12-12
CA2703158A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
MX2009008760A (es) Composicion para el tratamiento de enfermedades del cartilago.
MX2010004484A (es) Composicion para tratamiento de enfermedad de las articulaciones.
PH12015502854A1 (en) Methods, systems, and compositions for promoting bone growth
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
IL207713A0 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
EA201300471A1 (ru) Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3
EP1931266A4 (en) IMPLANTABLE PRODUCTS AND METHOD FOR TREATING MICRO-ARCHITECTURE-INGREDIBILITY OF BONE TISSUE
BRPI1010704A2 (pt) proteínas de fusão actriib truncadas
EA201001865A1 (ru) Противовоспалительные агенты
MX337614B (es) Tratamiento de lupus nefritis usando laquinimod.
PH12012501740A1 (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
IL266772B (en) Prevention and treatment of bone and cartilage damage or disease
EP1851237A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING BONE DISORDERS
WO2010071826A3 (en) Methods for treating osteoclast-related disease, compounds and compositions thereof
NZ597419A (en) Formulations for the treatment of deep tissue pain
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
MX2012006430A (es) Preparaciones de combinacion que comprenden un antagonista de citocina y un corticosteroide.
SG178975A1 (en) Indenone derivative and pharmaceutical composition comprising same
EA201200428A1 (ru) Композиция и способ для лечения ожирения
WO2007135505A8 (en) Veterinary pharmaceutical compositions for the treatment of pain and inflammation
EP2473037A4 (en) METHOD OF TREATING NEURODEGENERATIVE OR DEGENERATIVE NEUROMUSCULAR DISEASES AND THERAPEUTIC AGENT FOR TREATING THESE DISEASES
PL3478310T3 (pl) Kompozycje przydatne w zapobieganiu i/lub leczeniu zapalenia i bólu stawów i kości oraz uszkodzenia chrząstki
TW200806293A (en) Methods of treatment with CETP inhibitors
PH12015502165A1 (en) Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents

Legal Events

Date Code Title Description
FG Grant or registration